摘要:
A JNK inhibitor containing a compound having an isoquinolinone skeleton or a salt thereof, such as a compound represented by the formula wherein ring A and ring B are each an optionally substituted benzene ring, X is —O—, —N═, —NR3— or —CHR3—, R2 is an acyl group, an optionally esterified or thioesterified carboxyl group, an optionally substituted carbamoyl group or an optionally substituted amino group and the like, a broken line shows a single bond or a double bond, and R1 is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group and the like, and the like.
摘要:
A JNK inhibitor containing a compound having an isoquinolinone skeleton or a salt thereof, such as a compound represented by the formula wherein ring A and ring B are each an optionally substituted benzene ring, X is —O—, —N═, —NR3— or —CHR3—, R2 is an acyl group, an optionally esterified or thioesterified carboxyl group, an optionally substituted carbamoyl group or an optionally substituted amino group and the like, a broken line shows a single bond or a double bond, and R1 is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group and the like, and the like.
摘要:
Novel carbamate derivatives which are useful as drugs because of inhibiting activated blood coagulation factor X and thus exerting an anticoagulant effect. Compounds represented by the formula: wherein R1 represents a group represented by the formula: (wherein Y1 represents CH═CH, etc.), which may be substituted, etc.; the ring A represents an oxo-substituted nitrogen-containing heterocyclic ring which may be further substituted; R2 represents a hydrogen atom, optionally substituted C1-4 alkyl, etc.; R3 represents optionally substituted C1-4 alkyl, etc.; and Z represents an optionally substituted nitrogen containing heterocyclic group, etc., or salts thereof.
摘要翻译:新型氨基甲酸酯衍生物由于抑制活化凝血因子X而作为药物有用,因此起抗凝作用。 由下式表示的化合物:其中R 1表示由式(其中Y 1表示CH-CH等)表示的基团,其可以被取代等 。 环A表示可被进一步取代的含氧取代的含氮杂环; R 2表示氢原子,任选取代的C 1-4烷基等; R 3表示任选取代的C 1-4烷基等; Z表示任选取代的含氮杂环基等,或其盐。
摘要:
For the purpose of providing a GSK-3β inhibitor containing an oxadiazole compound or a salt thereof or a prodrug thereof useful as an agent for the prophylaxis or treatment of a GSK-3β-related pathology or disease, the present invention provides a GSK-3β inhibitor containing a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof or a prodrug thereof.
摘要:
The invention relates to a sample containing a gastric mucosa lavage fluid collected from a subject who has received a gastric mucus removal treatment and a method for detecting a disease-related marker using the same. By using the sample of the invention, the disease-related marker can be detected conveniently, less invasively, highly sensitively and highly accurately.
摘要:
A novel compound of the formula: A--Z--Ar.sup.1 1'CO--Ar.sup.2 wherein A is a condensed pyrimidinone or condensed pyridazinone ring; Ar.sup.1 and Ar.sup.2 are independently a ring; Z is a divalent group, or a salt thereof which have an excellent antitumor activity.
摘要:
Apparatus for removing an acidic component from a gas comprising two absorption columns for washing a crude gas by using two concentrations of alkali-containing aqueous solutions. The alkali-containing solution used in the first step has a pH of 6-13 and the solution used in the second step has a 0.3-2.5 N concentration. A specific gravity control device is used to control the concentration of the solution circulated for the second step. A pH control device is used to control the pH of the solution circulated for the first step. The pH control device controls a valve which regulates the addition of the second step solution into the tank of the first step solution as needed.
摘要:
The present invention relates to a GPR40 receptor function regulator comprising a fused imidazole compound represented by the formula: wherein each symbol is as defined in the specification, or a salt thereof or a prodrug thereof. The GPR40 receptor function regulator is useful as an agent for the prophylaxis or treatment of obesity, hyperinsulinemia, type 2 diabetes and the like.
摘要:
A compound represented by the formula (I): wherein ring A represents an aromatic ring; X represents a bond, oxygen, NR4 (R4 represents hydrogen, a hydrocarbon group, or a heterocyclic group), or alkylene; R1 represents a hydrocarbon group, or a heterocyclic group; R2 represents —COYR5 (Y represents a bond, alkylene, oxygen, sulfur, or NR6 (R6 represents hydrogen, a hydrocarbon group, or a heterocyclic group), and R5 represents a hydrocarbon group, or a heterocyclic group), a hydrocarbon group, or a heterocyclic group; and R3 represents a hydrocarbon group, a heterocyclic group, optionally substituted hydroxy, optionally substituted amino, or —S(O)nR7 (R7 represents a hydrocarbon group, or a heterocyclic group, and n is 0 to 2), a salt of the compound, or a prodrug or either is useful as an agent for modulating the function of an RFRP receptor.
摘要翻译:由式(I)表示的化合物:其中环A表示芳环; X表示键,氧,NR 4(R 4表示氢,烃基或杂环基)或亚烷基; R 1表示烃基或杂环基; R 2表示-COYR 5(Y表示键,亚烷基,氧,硫或NR 6(R 6) SUP>表示氢,烃基或杂环基),R 5表示烃基或杂环基),烃基或杂环基; 和R 3表示烃基,杂环基,任选取代的羟基,任选取代的氨基或-S(O)n R 7 (R 7表示烃基或杂环基,n为0〜2),化合物或前药的盐或其可用作调节其功能的试剂 RFRP受体。
摘要:
The present invention provides a TGR5 receptor agonist comprising a fused ring compound represented by the formula wherein ring A is an optionally substituted aromatic ring; and ring B′ is a 5- to 8-membered ring having one or more substituents or a salt thereof or a prodrug thereof, which is useful for the treatment of various diseases.